We’re joined by William Reinsch, former Commerce Department official and international trade expert at CSIS, for a timely conversation on how President Trump’s tariff policies, U.S.-China relations, and supply chain strategy are reshaping the pharmaceutical sector and American manufacturing. He lays out the challenges of reshoring, the case for trusted trade partnerships, and the economic risks of going it alone.
